Stay updated on Cabozantinib for NSCLC Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for NSCLC Brain Metastases Clinical Trial page.

Latest updates to the Cabozantinib for NSCLC Brain Metastases Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No user-facing changes to study details or page functionality are introduced.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedNo substantive content changes were detected. The page appears to have only visual/layout adjustments without altering study details.SummaryDifference0.1%

- Check34 days agoChange DetectedThe page now shows Revision: v3.4.2 and the older notices about funding and v3.4.1 have been removed; these are administrative updates that do not affect the trial’s content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a government funding notice banner and updated the site revision from v3.4.0 to v3.4.1. Both changes are administrative and do not alter study content or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedGlossary toggle added and capitalization fixes for labels, such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data,' plus the site revision banner updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision: v3.3.4 replaces the previous v3.3.3 in the page footer, indicating a minor version update that does not alter trial content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib for NSCLC Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for NSCLC Brain Metastases Clinical Trial page.